Orchard Capital Managment, LLC Akebia Therapeutics, Inc. Transaction History
Orchard Capital Managment, LLC
- $169 Million
- Q4 2024
A detailed history of Orchard Capital Managment, LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Orchard Capital Managment, LLC holds 60,710 shares of AKBA stock, worth $126,276. This represents 0.07% of its overall portfolio holdings.
Number of Shares
60,710
Previous 84,716
28.34%
Holding current value
$126,276
Previous $111,000
0.9%
% of portfolio
0.07%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding AKBA
# of Institutions
127Shares Held
57.4MCall Options Held
291KPut Options Held
179K-
Black Rock Inc. New York, NY11.6MShares$24.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$22.6 Million0.0% of portfolio
-
State Street Corp Boston, MA6.3MShares$13.1 Million0.0% of portfolio
-
Satter Management Co., L.P.5.75MShares$12 Million13.23% of portfolio
-
Geode Capital Management, LLC Boston, MA4.8MShares$9.97 Million0.0% of portfolio
About Akebia Therapeutics, Inc.
- Ticker AKBA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 183,848,992
- Market Cap $382M
- Description
- Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...